Niche CRO Services Asha Pharma specializes in crystallization and solid form screening and selection, offering a full suite of services from polymorph, salt, and cocrystal screening to crystallization process development and solid-state characterization. This positions them as a specialized CRO for pharmaceutical companies seeking formulation and process optimization, including challenging crystalline materials.

Solubility Optimization The firm highlights capabilities in salt screening and solubility measurement with FaSSIF/FeSSIF and related media, including investigations that yield salts with significantly improved FaSSIF solubility. This indicates strong value for clients aiming to enhance oral bioavailability and develop robust formulation strategies.

Scale-Ready Capabilities Services cover single crystal growth, crystallization screening for amorphous or difficult materials, and crystallization process development, suggesting capacity to support both early discovery screening and subsequent scale-up or tech transfer for manufacturing readiness.

Data and Compliance Readiness Comprehensive solid-state characterization and stability profiling (PXRD, DSC, TGA, SEM, DVS, PSD) plus pKa, Log P/log D, and solubility profiling indicate strong data packages suitable for regulatory submissions and robust quality-by-design (QbD) workflows.

Strategic Fit for Biopharma and Pharma Headquartered in San Diego with a focused, fee-for-service model and a lean team, Asha Pharma seems well-positioned to partner with mid-size biotech and pharma companies seeking specialized crystallography and solid-form insights without large CRO overhead, offering flexible collaboration and potentially faster turnaround.